Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis
Open Access
- 1 May 2014
- journal article
- research article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 20 (5), 416-423
- https://doi.org/10.1111/1469-0691.12363
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Evolution of a Pathogen: A Comparative Genomics Analysis Identifies a Genetic Pathway to Pathogenesis in AcinetobacterPLOS ONE, 2013
- Increase of Carbapenem-Resistant Acinetobacter baumannii Infection in Acute Care Hospitals in Taiwan: Association with Hospital Antimicrobial UsagePLOS ONE, 2012
- Impact of Carbapenem Resistance and Receipt of Active Antimicrobial Therapy on Clinical Outcomes of Acinetobacter baumannii Bloodstream InfectionsAntimicrobial Agents and Chemotherapy, 2011
- Risk factors and outcomes of imipenem–resistant Acinetobacter bloodstream infection in North–eastern MalaysiaAsian Pacific Journal of Tropical Biomedicine, 2011
- Epidemiology and Impact of Imipenem Resistance in Acinetobacter baumanniiInfection Control & Hospital Epidemiology, 2009
- Acinetobacter baumannii : Emergence of a Successful PathogenClinical Microbiology Reviews, 2008
- Acinetobacterinfections: a growing threat for critically ill patientsEpidemiology and Infection, 2007
- Attributable mortality of Acinetobacter baumannii: no longer a controversial issueCritical Care, 2007
- Quantifying heterogeneity in a meta-analysisStatistics in Medicine, 2002
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986